Destaca en este puesto — genera un currículum adaptado y una carta de presentación en aproximadamente un minuto.
Institut d'Investigació Biomèdica Sant Pau invites applications for a R2B - Senior Postdoctoral Researcher in the DNA Repair Syndromes and Cancer Predisposition Research Group. The role focuses on functional studies, advanced molecular biology techniques, and translational oncology research within a renowned international team.
The selected candidate will design and execute independent projects, supervise activities, and contribute to publications while working in a collaborative environment in
Organisation/Company Institut d'Investigació Biomèdica Sant Pau Research Field Other Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Application Deadline 25 Sep 2026 - 15:00 (Europe/Madrid) Country Spain Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Call for applications for a R2B - Senior Postdoctoral Researcher in the DNA Repair Syndromes and Cancer Predisposition Research Group. Application deadline: 22 September 2026, at 3:00 p.m.
The DNA Repair Syndromes and Cancer Predisposition Research Group, coordinated by Dr Jordi Surrallés, conducts research in the field of human genetic diseases characterized by a high predisposition to cancer.
Many of these syndromes are caused by mutations in genes involved in DNA repair. These genes play an important role in preventing the accumulation of mutations and tumor transformation.
Research into these syndromes is essential to understanding the mechanisms that protect us against cancer.
In recent years, the team has identified and studied new genes involved in these syndromes and has conducted therapeutic research that has led to the designation of orphan medicinal products by the European Medicines Agency.
Researchers in the group also participate in several clinical trials involving gene therapy and drug repurposing, and investigate DNA repair genes involved in these syndromes as therapeutic targets against cancer in the general population.
New strategies are increasingly being developed based on an in-depth understanding of the genetic causes of disease. Therefore, an accurate genetic diagnosis is important not only to provide appropriate genetic counselling and clinical follow-up for patients and their families, but also to provide personalized medicine based on genomic information.
The following will be valued